Minor clone of del(17p) as a predictor for relapse in multiple myeloma patients: A study by Jian Cui et al
In February 2024, a significant research article authored by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, was published in the internationally recognized journal Haematologica (IF=11.047). The study, entitled "Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma" marks a pivotal addition to the existing research on multiple myeloma, a type of blood cancer. This groundbreaking work illuminates the role of a minor clone of deletion 17p (del(17p)) in the relapse of the disease, providing critical insights that could significantly influence future treatment strategies and improve patient outcomes. The collaborative effort reflects an extensive investigation into the genetic underpinnings of multiple myeloma relapse, promising to enhance therapeutic approaches and contribute to the global endeavor to combat this challenging disease.